Titan Medical to merge with imaging firm Conavi, ending strategic review

The combined company will focus on selling Conavi’s cardiovascular imaging system used in minimally invasive procedures.

By Elise Reuter • March 19, 2024

Haemonetics to buy Attune Medical for $160M

Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.

By Susan Kelly • March 5, 2024

Baxter considers selling kidney care unit to private equity

The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.

By Elise Reuter • March 4, 2024

Agiliti to go private in $2.5B PE deal

After the transaction’s expected close in the first half of this year, Agiliti will no longer trade on the New York Stock Exchange.

By Susan Kelly • Feb. 26, 2024

Ex-Mazor exec convicted of insider trading conspiracy linked to $1.6B Medtronic deal

A federal jury found Doron Tavlin guilty on one count of conspiracy to commit insider trading and 10 counts related to securities fraud.

By Nick Paul Taylor • Feb. 22, 2024

The top medtech trends in 2024

Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

By MedTech Dive Staff • Jan. 31, 2024

Cook Medical sells ear, nose and throat devices to C2Dx

The transaction completes Cook’s divestiture of its otolaryngology, head and neck surgery product lines.

By Nick Paul Taylor • Jan. 26, 2024

Invitae sells reproductive health assets amid liquidity concerns

DNA testing firm Natera could pay up to $52.5 million total, and plans to move Invitae’s customers to its own tests.

By Elise Reuter • Jan. 22, 2024

Integer acquires Pulse Technologies for $140M

Pulse specializes in the micro machining of components for medical devices used in markets such as structural heart.

By Nick Paul Taylor • Jan. 16, 2024

5 medtech trends to watch in 2024

From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.

By Ricky Zipp • Jan. 9, 2024

Boston Scientific to buy Axonics for $3.7B to gain incontinence treatment

The acquisition provides a high-growth addition to Boston Scientific’s urology business, analysts said.

By Susan Kelly • Jan. 8, 2024

‘Healthy pullback’: GSR Ventures’ Sunny Kumar on normalizing digital health funding, accelerating M&A in 2024

Sunny Kumar discusses digital healthcare investment, the landscape for M&A and when the public markets could open back up. 

By Emily Olsen • Jan. 8, 2024

Roche to buy LumiraDx’s point-of-care technology for $295M

LumiraDx faces financial pressures amid declining test sales and a potential delisting from the Nasdaq.

By Elise Reuter • Jan. 2, 2024

Roundup: Illumina’s long goodbye to cancer test maker Grail

From the start, the DNA sequencing leader faced pressure to unwind its $8 billion acquisition of the cancer screening developer. As 2023 drew to a close, it has finally agreed.

By Susan Kelly • Dec. 21, 2023

Stryker buys joint replacement business Serf Sas

The purchase is expected to complement Stryker’s business in Europe and its joint replacement portfolio.

By Elise Reuter • Dec. 20, 2023

Roundup: Medtech M&A slump continues but analysts predict uptick in 2024

Globus Medical and Thermo Fisher were among the companies to announce billion dollar deals this year, while Medtronic and Boston Scientific called off acquisitions.

By Nick Paul Taylor • Dec. 19, 2023

Illumina to part with Grail, ending battle with regulators

Activist investor Carl Icahn, who is suing the company over its acquisition of Grail, continued to push for the removal of several board members in a letter to fellow shareholders.

By Susan Kelly • Dec. 18, 2023

Zimvie to sell spine business for $375M

Zimvie said the sale to H.I.G. Capital will leave the company focused on its dental business and help reduce debt.

By Elise Reuter • Dec. 18, 2023

Integra to buy J&J’s Acclarent for $275M

Integra said the purchase, which includes a portfolio of balloon dilation products for the sinuses and eustachian tube, would make it a market leader in ENT procedures.

By Elise Reuter • Dec. 13, 2023

Illumina prepares to divest Grail with Form 10 filing

The DNA sequencer is preparing to unwind its 2021 acquisition of the liquid biopsy test maker while still appealing orders to do so from regulators in the U.S. and Europe.

By Susan Kelly • Dec. 13, 2023

Edwards to spin off its critical care business

Edwards is the latest healthcare firm to spin off a business to focus on specific markets, following larger companies like Johnson & Johnson and GE.

By Ricky Zipp • Dec. 8, 2023

J&J heats up LAA closure competition with $400M Laminar buy

Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.

By Susan Kelly • Nov. 30, 2023

3 medtech spinoffs that reshaped the industry in 2023, and what to expect next

GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.

By Susan Kelly • Nov. 29, 2023

Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant

Bioventus’ protracted buyout bid ultimately fell apart and opened the door to Smith & Nephew.

By Nick Paul Taylor • Nov. 27, 2023

4 takeaways from Stryker’s investor day

The company’s expected return to pre-pandemic operating margins, procedure backlogs and weight loss drugs were among the topics discussed at Wednesday’s event.

By Elise Reuter • Nov. 9, 2023